| 000 | 00918nam a22003377a 4500 | ||
|---|---|---|---|
| 008 | 130708b xxu||||| |||| 00| 0 eng d | ||
| 020 | _a978 90 382 2172 4 | ||
| 040 | _cVAD | ||
| 041 | _aEngels | ||
| 100 | _aVander Laenen, Freya | ||
| 245 | _aAnalysis and optimization of substitution treatment in Belgium (SUBANOP) | ||
| 260 |
_aGent _bAcademia Press _c2013 |
||
| 300 | _aXIV, 210 p. | ||
| 490 | _aScience and society | ||
| 650 | _adrugs | ||
| 650 | _aheroïne | ||
| 650 | _amethadon | ||
| 650 | _abuprenorfine | ||
| 650 | _ahulpverlening | ||
| 650 | _afarmacotherapie | ||
| 650 | _aBelgië | ||
| 650 | _aonderzoeksrapporten | ||
| 650 | _autilization studies | ||
| 700 | _aVanderplasschen, Wouter | ||
| 700 | _aSmet, Valérie | ||
| 700 | _aDe Maeyer, Jessica | ||
| 700 | _aBuckinx, Margaux | ||
| 700 | _aVan Audenhove, Sharon | ||
| 700 | _aAnsseau, Marc | ||
| 700 | _aDe Ruyver, Brice | ||
| 999 |
_c16940 _d16940 |
||